Chuyển sang chế độ ngoại tuyến với ứng dụng Player FM !
Podcast đáng để nghe
TÀI TRỢ BỞI
1 The red and blue pills of Virtual Twins 40:51
#24 A week in the name of medicines safety – part 1
Manage episode 424661241 series 2749727
To mark #MedSafetyWeek, which takes place from 6–12 November, we’re releasing a special two-part episode on pharmacovigilance communication campaigns. In this first part, we speak to Mitul Jadeja from the Medicines and Healthcare products Regulatory Agency in the UK about under-reporting and how initiatives like #MedSafetyWeek can help draw attention to medicines safety.
Tune in to find out:
- Why under-reporting plagues all pharmacovigilance systems
- What regulators can do to encourage people to report side effects
- Why we need reports from both patients and healthcare professionals
Want to know more?
Here are the studies cited in the episode:
- A BMJ study in 2022 measured the burden and associated cost of adverse drug reactions, polypharmacy and multimorbidity at a hospital in the UK.
- In 1976, Inman proposed a theoretical model, known as the ‘seven deadly sins’, to explain why healthcare professionals fail to report adverse drug reactions. This recent systematic review in Drug Safety expands on that.
- The SCOPE Joint Action project aimed to enhance pharmacovigilance in the EU and delivered practical guidance for regulators.
- The first UK study to compare Yellow Card reports from patients and healthcare professionals was published in 2012.
To join the #MedSafetyWeek campaign next week, follow the hashtag online and check out the campaign website for free social media materials.
Finally, don’t forget to tune in on 13 November for part 2 of this podcast, where we’ll hear from #MedSafetyWeek advocates in Iraq, Luxembourg, and Namibia about their experience with the campaign. Read a preview of the conversation on Uppsala Reports.
Join the conversation on social media
Follow us on X, LinkedIn, or Facebook and share your thoughts about the show with the hashtag #DrugSafetyMatters.
Got a story to share?
We’re always looking for new content and interesting people to interview. If you have a great idea for a show, get in touch!
About UMC
Read more about Uppsala Monitoring Centre and how we work to advance medicines safety.
Chương
1. #24 A week in the name of medicines safety – part 1 (00:00:00)
2. Intro (00:00:15)
3. Welcome, Mitul! (00:01:49)
4. Why we need communications campaigns (00:01:58)
5. Barriers to reporting (00:06:07)
6. Different reporters, different perspectives (00:09:45)
7. Other interventions to prompt reporting (00:14:23)
8. Global versus local (00:19:08)
9. Future of #MedSafetyWeek (00:22:55)
10. Outro (00:25:19)
52 tập
Manage episode 424661241 series 2749727
To mark #MedSafetyWeek, which takes place from 6–12 November, we’re releasing a special two-part episode on pharmacovigilance communication campaigns. In this first part, we speak to Mitul Jadeja from the Medicines and Healthcare products Regulatory Agency in the UK about under-reporting and how initiatives like #MedSafetyWeek can help draw attention to medicines safety.
Tune in to find out:
- Why under-reporting plagues all pharmacovigilance systems
- What regulators can do to encourage people to report side effects
- Why we need reports from both patients and healthcare professionals
Want to know more?
Here are the studies cited in the episode:
- A BMJ study in 2022 measured the burden and associated cost of adverse drug reactions, polypharmacy and multimorbidity at a hospital in the UK.
- In 1976, Inman proposed a theoretical model, known as the ‘seven deadly sins’, to explain why healthcare professionals fail to report adverse drug reactions. This recent systematic review in Drug Safety expands on that.
- The SCOPE Joint Action project aimed to enhance pharmacovigilance in the EU and delivered practical guidance for regulators.
- The first UK study to compare Yellow Card reports from patients and healthcare professionals was published in 2012.
To join the #MedSafetyWeek campaign next week, follow the hashtag online and check out the campaign website for free social media materials.
Finally, don’t forget to tune in on 13 November for part 2 of this podcast, where we’ll hear from #MedSafetyWeek advocates in Iraq, Luxembourg, and Namibia about their experience with the campaign. Read a preview of the conversation on Uppsala Reports.
Join the conversation on social media
Follow us on X, LinkedIn, or Facebook and share your thoughts about the show with the hashtag #DrugSafetyMatters.
Got a story to share?
We’re always looking for new content and interesting people to interview. If you have a great idea for a show, get in touch!
About UMC
Read more about Uppsala Monitoring Centre and how we work to advance medicines safety.
Chương
1. #24 A week in the name of medicines safety – part 1 (00:00:00)
2. Intro (00:00:15)
3. Welcome, Mitul! (00:01:49)
4. Why we need communications campaigns (00:01:58)
5. Barriers to reporting (00:06:07)
6. Different reporters, different perspectives (00:09:45)
7. Other interventions to prompt reporting (00:14:23)
8. Global versus local (00:19:08)
9. Future of #MedSafetyWeek (00:22:55)
10. Outro (00:25:19)
52 tập
Tất cả các tập
×1 #35 Veterinary pharmacovigilance part 2 – James Mount 41:42
1 #34 Veterinary pharmacovigilance, Part I – James Mount 47:21
1 #33 Narrative fields and signal assessors, an exploratory study – Joana Félix and Alem Zekarias 38:43
1 #32 Pharmacovigilance in older adults – Giovanni Furlan 47:51
1 #31 A guide to reporting disproportionality analyses – Michele Fusaroli and Daniele Sartori 42:45
1 Uppsala Reports Long Reads – Weeding out duplicates to better detect side effects 25:02
1 Uppsala Reports Long Reads – Ensuring trust in AI/ML when used in pharmacovigilance 30:18
1 #30 Preventing and reporting medication errors – Rabat CC & UMC 33:58
1 #29 When medicines change our behaviour – Michele Fusaroli 30:30
1 #28 Catching black swans – François Montastruc 27:21
1 #27 When drugs damage the liver – Rita Baião 28:30
1 #26 What's trending in pharmacovigilance? – Angela Caro 28:06
1 #25 A week in the name of medicines safety – part 2 33:13
1 #24 A week in the name of medicines safety – part 1 27:09
1 Uppsala Reports Long Reads – The colour of signals 33:59
1 #11 Talking about vaccine safety – Anthony Cox & Daniel Salmon 28:52
1 Uppsala Reports Long Reads – The KIDs List 31:08
1 Uppsala Reports Long Reads – Convincing the vaccine hesitant 34:52
1 #10 Tailoring drug therapy to your genes – Qun-Ying Yue 29:37
1 #9 Keeping vaccines safe – Helena Sköld & Annette Rudolph 26:44
1 Uppsala Reports Long Reads – Substandard and falsified COVID-19 vaccines in the Americas 21:06
1 #8 How do we change behaviour around antimicrobial resistance? 47:39
1 Uppsala Reports Long Reads – Into the infodemic 27:17
1 #7 The challenge of rare diseases – Christina Ström Möller 24:15
1 Uppsala Reports Long Reads – Africa integral to evolution of pharmacogenomics research 12:19
1 #6 Intuition in pharmacovigilance – Eugene van Puijenbroek 25:04
1 Uppsala Reports Long Reads – Patient's advocate 9:51
1 Uppsala Reports Long Reads – Vaccination errors risk harm and damage trust 9:21
1 #5 Restoring invisible and abandoned trials – Peter Doshi 34:27
1 #4 Communicating science through film – Matthew Barwick 28:40
1 Uppsala Reports Long Reads – Empowering patients as partners 42:43
1 #23 Assessing safety in clinical trials – Marianne Lunzer & Sanja Prpić 31:06
1 #22 Reforming pharmacovigilance education – Michael Reumerman 32:54
1 #21 Unlocking the power of real-world data – Patrick Ryan 33:42
1 #20 The evidence for signals – Daniele Sartori 45:41
1 Uppsala Reports Long Reads – Unmasking data in the COVID-19 vaccine era 21:19
1 #19 Lessons in pandemic pharmacovigilance – Elena Rocca 33:11
1 #18 The IDMP standards explained – Malin Fladvad & Olle Lagerlund 23:06
1 #17 Why we need vaccine surveillance systems – Madhava Balakrishnan 27:30
1 #16 How drug safety can help fight resistant bugs – Jean Marie Vianney Habarugira & Albert Figueras 33:42
1 #15 Safety of HIV medications – Henry Zakumumpa 33:19
1 #14 Advancing pharmacovigilance in Africa – Eleni Aklillu & Abbie Barry 37:20
1 #13 How to talk about risks – Alexandra Freeman 38:16
1 Uppsala Reports Long Reads – Safety issues faced by refugee communities 25:08
1 #12 Improving signal detection with vigiGroup – Jim Barrett & Joe Mitchell 23:21
1 Uppsala Reports Long Reads – Found in space 22:34
1 Uppsala Reports Long Reads – 10 critical steps for patient safety 17:39
1 #3 Navigating the plant names jungle – Bob Allkin 40:16
1 #2 Why we should listen to patients – Linda Härmark 28:36
1 Uppsala Reports Long Reads – Philosophy of science meets patient safety 12:32
1 Uppsala Reports Long Reads – Ending the pregnant pause 25:21
Chào mừng bạn đến với Player FM!
Player FM đang quét trang web để tìm các podcast chất lượng cao cho bạn thưởng thức ngay bây giờ. Đây là ứng dụng podcast tốt nhất và hoạt động trên Android, iPhone và web. Đăng ký để đồng bộ các theo dõi trên tất cả thiết bị.